Does GLATIRAMER Cause Embolia cutis medicamentosa? 78 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Embolia cutis medicamentosa have been filed in association with GLATIRAMER (GLATIRAMER ACETATE). This represents 0.2% of all adverse event reports for GLATIRAMER.
78
Reports of Embolia cutis medicamentosa with GLATIRAMER
0.2%
of all GLATIRAMER reports
0
Deaths
19
Hospitalizations
How Dangerous Is Embolia cutis medicamentosa From GLATIRAMER?
Of the 78 reports, 19 (24.4%) required hospitalization, and 1 (1.3%) were considered life-threatening.
Is Embolia cutis medicamentosa Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLATIRAMER. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does GLATIRAMER Cause?
Injection site pain (5,003)
Multiple sclerosis relapse (3,695)
Drug ineffective (3,321)
Injection site reaction (3,317)
Multiple sclerosis (2,596)
Injection site erythema (2,560)
Fatigue (2,408)
Dyspnoea (2,364)
Injection site mass (2,172)
Injection site swelling (1,836)
What Other Drugs Cause Embolia cutis medicamentosa?
DICLOFENAC (337)
PENICILLIN G BENZATHINE (46)
LIDOCAINE (45)
BUPRENORPHINE (13)
IBUPROFEN (11)
TRIAMCINOLONE ACETONIDE (11)
CEFTRIAXONE (10)
METHYLPREDNISOLONE (10)
METHOCARBAMOL (9)
DICLOFENAC\DICLOFENAC (8)
Which GLATIRAMER Alternatives Have Lower Embolia cutis medicamentosa Risk?
GLATIRAMER vs GLECAPREVIR\PIBRENTASVIR
GLATIRAMER vs GLEEVEC
GLATIRAMER vs GLICLAZIDE
GLATIRAMER vs GLIMEPIRIDE
GLATIRAMER vs GLIMEPIRIDE\ROSIGLITAZONE